KASINGER JAMES R. bought CRSP
October 6, 2026 · Form 4 insider transaction
KASINGER JAMES R. bought 1,990 shares of CRISPR Therapeutics AG at $13.62 per share, a transaction worth $27.1K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,990
Price
$13.62
Total value
$27.1K
InsiderKASINGER JAMES R.
RoleOfficer
SecurityCommon Shares
Transaction codeM: Option exercise
Transaction dateOctober 6, 2026
Filing dateOctober 8, 2026
Shares owned after96,774
OwnershipDirect
10b5-1 planNo
AmendedNo